ADHD Is Explicitly Covered — and Often Overlooked
The federal multidistrict litigation was formally titled 'In re Acetaminophen — ASD/ADHD Products Liability Litigation' — the 'ADHD' is right there in the name. Yet the vast majority of public coverage focuses on autism. ADHD families represent a distinct claimant population with their own eligibility criteria, their own damages profile, and their own evidence requirements. The JAMA Psychiatry 2020 cord blood study — which used objective umbilical cord blood biomarkers rather than maternal self-report — found that children in the highest acetaminophen exposure group had a 2.86 times greater risk of ADHD compared to the lowest-exposure group. This is a striking risk ratio, and it is the foundation of the ADHD claim. If your child has a formal ADHD diagnosis and you used any acetaminophen product during pregnancy, you very likely qualify to speak with an attorney about a potential claim.
Economic Damages for ADHD: $1.27 Million Lifetime Earnings Gap
ADHD carries well-documented economic consequences. A peer-reviewed economic study found that individuals with ADHD face an estimated $1.27 million lifetime earnings gap compared to neurotypical peers, attributable to lower educational attainment, higher job turnover, reduced earning capacity, and more frequent employment gaps. Beyond earnings, ADHD damages include: costs of behavioral therapy during childhood (ABA and parent training are first-line treatments for young children); stimulant and non-stimulant medication costs across a lifetime (often $200–$400/month without insurance); educational interventions, tutoring, and IEP services; higher rates of accidental injury, legal involvement, and impulsive decision-making consequences; and emotional distress from academic failure, peer rejection, and self-esteem impact. These economic damages are quantifiable by expert economic witnesses and support meaningful claim values even for ADHD-only diagnoses without autism.
ADHD-Only Eligibility Checklist
To qualify as an ADHD-only claimant: your child must have a formal ADHD diagnosis (predominantly inattentive, predominantly hyperactive-impulsive, or combined presentation) by a licensed clinician — a pediatrician, child psychiatrist, or psychologist. The diagnosis must be documented (school IEP, 504 plan, prescription records, or a formal evaluation report). You must have used any acetaminophen product — Tylenol or any store brand — during your pregnancy. There is no minimum trimester requirement, though second and third trimester exposure is most strongly associated with neurodevelopmental risk in the research. The brand does not matter: Walmart Equate, CVS brand, Walgreens brand, Target Up & Up, Kirkland, or any generic acetaminophen is the same as Tylenol for purposes of this claim. ADHD resulting from a known genetic cause (e.g., a confirmed chromosomal abnormality) would not qualify.
Frequently Asked Questions
Related Pages
Tylenol Liver Damage Lawsuit
Acetaminophen — the active ingredient in Tylenol — is the leading cause of acute liver failure in the United States, responsible for approximately 56,000 emergency room visits, 26,000 hospitalizations, and nearly 500 deaths each year. Lawsuits allege that McNeil Consumer Healthcare and parent company Johnson & Johnson failed to adequately warn consumers about the narrow margin between a therapeutic dose and a potentially fatal overdose. Even doses only slightly above the recommended amount, especially when combined with alcohol use or taken across multiple acetaminophen-containing products, can cause catastrophic liver damage. If you or a loved one suffered acute liver failure, liver transplant, or death linked to acetaminophen use, you may be eligible for compensation. These liver damage claims are separate from the Tylenol autism/ADHD litigation — they involve direct injury to the person who took the medication.
Learn moreLearn moreLearn moreLearn moreLearn moreLearn moreLearn moreTylenol Autism Lawsuit Lawsuit
Acetaminophen — sold under the brand name Tylenol by Kenvue (formerly Johnson & Johnson) and as dozens of store-brand generics by Walmart, CVS, Walgreens, Target, Costco, Meijer, and others — was the most commonly used pain reliever during pregnancy in the United States for decades. Starting with a landmark 2018 American Journal of Epidemiology meta-analysis of 130,000 mother-child pairs, and culminating in a 2021 consensus statement signed by 91 scientists published in Nature Reviews Endocrinology, accumulating evidence linked prolonged prenatal acetaminophen exposure to significantly elevated risks of autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD). The federal multidistrict litigation, MDL-3043 (In re Acetaminophen — ASD/ADHD Products Liability Litigation) in the Southern District of New York, was dismissed in August 2024 after Judge Denise L. Cote excluded all plaintiffs' general causation experts under the Daubert standard. Critically, the Second Circuit Court of Appeals heard oral arguments on November 17, 2025 — and two of the three judges on the panel openly questioned whether Judge Cote acted too aggressively in excluding the expert testimony. A reversal by the Second Circuit could reinstate thousands of federal cases. Separately, California state courts (Alameda County) and Illinois state courts (St. Clair, Madison, and Cook counties) have active acetaminophen-autism cases proceeding under the Frye admissibility standard, which does not apply the same gatekeeping test that closed the federal MDL. Store-brand acetaminophen users have the same legal claims as Tylenol brand users — the failure-to-warn theory applies equally to Walmart's Equate brand, CVS Health brand, Walgreens brand, Costco Kirkland brand, and all other private-label acetaminophen products.
View full case overview